Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS

AIDS

Volumn 11, Issue 4, 1997, Pages 525-531

  Hermans, Philippe ^a   Lundgren, Jens ^b   Sommereijns, Bernadette ^a   Katlama, Christine ^c   Chiesi, Antonio ^d   Goebel, Frank Detlef ^e   Gonzales Lahoz, Juan ^f   Proenza, Rei ^g   Barton, Simon E ^h   Pedersen, Court ^b   Clumeck, Nathan ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b HVIDOVRE HOSPITAL   (Denmark)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f Hospital del Rey   (Spain)

^g HOSPITAL CURRY CABRAL   (Portugal)

^h John Hunter Clinic   (United Kingdom)

Author keywords

AIDS; Epidemiology; Europe; Female; Kaposi's sarcoma; Prognosis; Risk factors; Survival

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HUMAN; INFECTION RISK; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONBIOLOGICAL MODEL; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL;

EID: 8044223397     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199704000-00017     Document Type: Article

References (33)

1. Centers for Disease Control: Revision of the CDC surveillance case definition for the acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1S):3S-1.5S.
2. Selik RM, Starcher ET, Curran JW: Opportunistic diseases reported in AIDS patients: frequencies, associations and trends. AIDS 1987, 1:175-182.
3. Biggar RJ, Burnett W, Mikl J, Nasca P: Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989, 43:979-985.
4. Beral V, Bull D, Darby S. et al.: Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual and bisexual men with AIDS. Lancet 1992, 339:632-635.
5. Beral V, Peterman TA, Berkelman RL, Jaffe HW: Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990, 335:125-128.
6. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
7. Friedman-Kien AE, Laubenstein LJ, Rubinstein P, et al.: Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 1982, 96:693-700.
8. Haverkos HW, Drotman DP, Morgan M: Prevalence of Kaposi's sarcoma among patients with AIDS [letter]. N Engl J Med 1985, 312:1518.
9. Hermans P, Lundgren J, Sommereijns B, Clumeck N, and the AIDS in Europe Study Group: Epidemiology and survival of AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retrovirus 1994, 10 (suppl 3):S78.
10. Hermans P, Clumeck N: Kaposi's sarcoma in patients infected with human immunodeficiency virus (HIV): an overview. Cell Mol Biol 1995, 3:357-364.
11. Parente F, Cernuschi M, Orlando G, Rizzardini G, Lazzarin A, Bianchi Porro G: Kaposi's sarcoma and AIDS: frequency of gastrointestinal involvement and its effect on survival. Scand J Gastroenterol 1991, 26:1007-1012.
12. Rutherford GW, Schwarcz SK, Lemp GF, et al.: The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Infect Dis 1989, 159:569-572.
13. Tappero JW, Conant MA, Wolfe SF, Berger TG: Kaposi's sarcoma. J Am Acad Dermatol 1993, 127:1479-1481.
14. Witte MH, Stuntz M, Witte CL, Way D: AIDS, Kaposi's sarcoma, and the gay population, Int J Dermatol 1989, 28:585-586.
15. Chang Y. Cesarman E, Pessin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
16. Salahuddin SZ, Nakamura S, Biberfeld P, et al.: Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988, 242:430-433.
17. Ensoli B, Gallo RC: Pathogenesis of AIDS-associated Kaposi's Sarcoma. Hematol Oncol Clin North Am 1991, 5:281-295.
18. Ensoli B, Barillari B, Salahuddin SZ, Gallo RC, Wong Staal E: Tat-protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 345:84-86.
19. Ensoli B, Nakamura S, Salabuddin SZ, et al.: AIDS Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243:223-226.
20. Lunardi-Iskandar Y, Bryant JI, Zeman RA, et al.: A pregnancy hormone human chorionic gonadotropin blocks tumorigenesis and metastasis of Kaposi's sarcoma cells (KS Y-1) in immunodeficient mice. Nature 1995, 375:64-68.
21. Lbrahini SH, Sunkutu MR, Mwansa N: Epidemiological and clinical features of Kaposi's sarcoma in adults in Zambia. IX International Conference on AIDS. Berlin, June 1993 [abstract WS B15-1].
22. Noel JC, Hermans P, André J, et al.: Herpes virus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiologic forms, clinical spectrum and histological features. Cancer 1996, 77:2132-2136.
23. Pandolfi E: Role of cytokines in the pathogenesis of HIV disease and their potential use in treatment. Forum Trends Exp Clin Med 1993, 3:448-461.
24. De Jarlais DC, Stoneburner R, Thomas P, Friedman SR: Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet 1987, ii:1024-1025.
25. Harnly ME, Swan SH, Holly EA, Keller A, Padian N: Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of AIDS. Am J Epidemiol 1988, 128:261-267.
26. Lundgien JD, Melbye M, Pedersen C, Rosenberg PS, Gerstoft J: Changing patterns of Kaposi's sarcoma in Danish AIDS patients with complete follow up. Am J Epidemiol 1995, 151:652-658.
27. Lundgren JD, Pedersen C, Clumeck N, et al.: Survival differences in European patients with AIDS, 1979-1989. Br Med J 1994, 308:1068-1073.
28. Hermans P, Lundgren JD, Sommereijns B, et al.: Epidemiology of AIDS related Kaposi's sarcoma in Europe over 10 years. AIDS 1996, 10:911-917.
29. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE: Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Arch Intern Med 1994, 154:566-572.
30. Mitsuyasu RT, Groopman JE: Biology and therapy of Kaposi's sarcoma. Semin Oncol 1984, 11:53-59.
31. Vadhan-Raj S, Wong G, Gnecco C, et al.: Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome. Cancer Res 1986, 46:417-425.
32. Mocrott AJ, Lundgien JD, d'Arminio Monforte A, et al.: Survival of AIDS patients according to type of AIDS defining event. Int J Lpidemiol 1997 (in press).
33. Morfeldt L, Iorssander J: Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994, 26:749-752.